WHO grade II and III meningiomas: a study of prognostic factors. - Wikidata - awgldk - TriplyDB

WHO grade II and III meningiomas: a study of prognostic factors.

WHO grade II and III meningiomas: a study of prognostic factors.

http://www.wikidata.org/entity/Q51822733

about

Management of intracranial meningiomas in Enugu, Nigeria Preoperative radiologic classification of convexity meningioma to predict the survival and aggressive meningioma behavior.Prognostic factors for survival in patients with high-grade meningioma and recurrence-risk stratification for application of radiotherapy.Caspase-3 and survivin expression in primary atypical and malignant meningiomas Double trouble: a tale of two radio-treatments.Pediatric meningiomas in The Netherlands 1974-2010: a descriptive epidemiological case study.Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma Expression of c-MET in Invasive Meningioma A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma.Meningiomas with Rhabdoid or Papillary Components : Prognosis and Comparison with Anaplastic Meningiomas.Relation of apparent diffusion coefficient with Ki-67 proliferation index in meningiomas.Anatomic location is a risk factor for atypical and malignant meningiomas.A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas.Pediatric microcystic meningioma: a clinical, histological, and radiographic case-based review.Malignant potential of skull base versus non-skull base meningiomas: clinical series of 1,663 cases.Patterns of relapse and growth kinetics of surgery- and radiation-refractory meningiomas.Recurrent meningioma with malignant transformation: a case report and literature review.Predictors of Treatment Response and Survival Outcomes in Meningioma Recurrence with Atypical or Anaplastic Histology.Prognostic significance of preoperative neutrophilia on recurrence-free survival in meningioma.Atypical and anaplastic meningioma: outcomes in a population based study.Checkpoint inhibition in meningiomas.Longitudinal experience with WHO Grade III (anaplastic) meningiomas at a single institution.Cytotoxic effects of statins and thiazolidinediones on meningioma cells.World Health Organization grade II meningiomas.Multimodal optical analysis of meningioma and comparison with histopathology.Extent of resection and overall survival for patients with atypical and malignant meningioma.World Health Organization grade III meningiomas. A retrospective study for outcome and prognostic factors assessment.The Role of Adjuvant Treatment in Patients with High-Grade Meningioma Review of Current Evidence Regarding Surgery in Elderly Patients with Meningioma.Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations PIK3CA mutations in meningioma.The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells.Early postoperative radiotherapy improves progression free survival in patients with grade 2 meningioma.Epidemiology of meningioma in the United Kingdom.uPA/PAI-1 expression and uPA promoter methylation in meningiomas.Prediction of high-grade meningioma by preoperative MRI assessment.Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma.Significance of COX-2 and VEGF expression in histopathologic grading and invasiveness of meningiomas.Survival benefit of postoperative radiation in papillary meningioma: Analysis of the National Cancer Data Base.The Simpson grading in meningioma surgery: does the tumor location influence the prognostic value?

P2860

Q30574316-7A2B191B-30C0-49ED-98B9-FEB43C9C88BA Q30912220-30AD8B7B-89B1-4112-B8EE-DD7F6F2FB914 Q33599285-888600E6-C0A0-426C-B007-3926F4C18F77 Q33771661-1022E08E-92D2-498F-9839-85EBD8006ED8 Q34220119-E14F1100-4FBE-49F3-826A-D0A5FAB954B6 Q34250513-0EF2ACD0-182D-4E0F-B0FB-06F4497404F3 Q34359681-0DF2EF34-4896-4D4F-9193-27E4FE15DE31 Q35170717-81AA12E2-9D16-4FC3-BD29-695F6D8D73D3 Q36493847-38E7DF88-B7AD-4960-AABD-A3188770CC74 Q37112567-79F0800F-A34C-4952-971A-1503831F33F2 Q37177786-AE50BF7D-0643-448F-90F2-BDD3548EDB0D Q37226853-879CDF55-16EA-4728-B2F2-A804AA437C97 Q37581072-993BFD8C-97C2-4164-920F-8DD48A21A4FF Q38068323-34657589-85F1-485B-B855-DB09626696B3 Q38074045-3274DF8D-3910-429D-86A5-095552AC33E7 Q38430591-29292239-5D64-4E0A-9AF0-028EA3BFBBE1 Q38656468-852880D6-C28C-470B-A47B-AF3F714439B0 Q38711744-A19B936E-E99E-4173-A4A1-41403B6C8FE7 Q38771012-AF16ED1C-861E-4CA6-9535-85F54DB3560C Q38827423-4DB33CC6-0B00-4F13-80F4-E725248E965E Q38838646-6462C31F-B92B-45F8-A019-FA38918F8669 Q39172845-D7823E05-EC22-4E26-81CD-44FAAB0F2694 Q39661946-F0B4A8F6-8267-4FE1-9881-A43DB5A3ECCD Q39884623-C5ED516F-937C-493A-9475-0A2511FC6A50 Q40001620-FA1C559C-600C-4E22-BF04-89FE9D04EAD1 Q40606004-DA895A9A-91C0-4EFB-BBAB-47E291B4BE24 Q40812108-C3586B3A-51EA-4535-AF36-971C3DF75A65 Q41271334-0744E483-1858-4253-97A3-519AF2302337 Q42257960-36F4F295-E906-4CF2-8272-25A45D125A64 Q42548316-4FF3D5C6-F3DB-49E9-8479-EC7A0974A0E5 Q42908544-0D062C34-6C55-4E19-AAB8-2553FAFB044E Q42927241-3DFA3365-87A0-47B4-8530-2D235B2F00A3 Q43432933-AE42AE2F-FA4F-4814-B415-AB4DFB28A0B6 Q43870265-A6D0D4E4-BCD0-480A-B137-19A65E2E9B31 Q43951136-47D3E6C9-210D-4DEB-B480-7AB4436DD302 Q44839894-3D1E213B-8FA6-4BD5-86F6-441F41C40FBD Q46449538-45CCB368-8059-4647-B164-B0572E9072E7 Q46649981-C0B8BA3A-2702-4D54-A7B4-E359AFACFB5E Q47621240-20A42EFD-2F99-4860-A70B-4000721C5A34 Q47758126-5E6AB45C-E16A-470A-A3D8-46A3596DBD94

P2860

WHO grade II and III meningiomas: a study of prognostic factors.

http://www.wikidata.org/entity/Q51822733

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

WHO grade II and III meningiomas: a study of prognostic factors.

@en

WHO grade II and III meningiomas: a study of prognostic factors.

@nl

type

label

WHO grade II and III meningiomas: a study of prognostic factors.

@en

WHO grade II and III meningiomas: a study of prognostic factors.

@nl

prefLabel

WHO grade II and III meningiomas: a study of prognostic factors.

@en

WHO grade II and III meningiomas: a study of prognostic factors.

@nl

P1433

Q51822733-68570F25-C79B-4F5B-8A00-432A6A629D9D

P1476

Q51822733-6B796ECE-C1A8-4E5B-973D-60A9376B1D86

P2093

Q51822733-2D4680CB-D54C-4575-BE56-289C74B3C281

Q51822733-3867E4AF-2EF6-4723-A557-475E7CBEDBC1

Q51822733-4DC298E6-7115-468B-8EB2-C2847F9E26E5

Q51822733-58BA550E-8386-4D5E-A7AE-F4F2F9BD8A4F

Q51822733-68927D84-968C-493A-916E-9C3AD067AC12

Q51822733-74AA5772-4BB7-4A4B-8C0F-B988BB492A22

Q51822733-9A811D1B-5327-44BC-9D38-00249A665DA1

Q51822733-E2E86E60-92D8-45B3-BE24-771EE76032BE

P2860

Q51822733-0D7B657D-63AB-467D-BCEA-9EA34A51C96F

Q51822733-1198D381-2F66-48C9-8EFC-231E2F3E82E0

Q51822733-20C45F88-D752-435D-BC49-EE1C6DAC2339

Q51822733-3B4C8C06-DF54-4BB0-9BB9-615BF1A73A14

Q51822733-4BF1E490-07B6-4A76-905B-3A8278DBED03

Q51822733-52AACE21-BD39-4D2D-BE8B-2FE276E1899B

Q51822733-6139E1CA-B7A6-4CA5-A823-64038EF15A0C

Q51822733-68C56983-2796-4CF2-8B17-4C126847FFCD

Q51822733-718ABF6D-0C88-480D-A35E-0411F831444C

Q51822733-78796972-FD86-466D-9FE3-C8211630A2CA

P2888

Q51822733-15F9D9AB-42DD-4E3D-AE8B-E10AA5227A94

P304

Q51822733-E96AD07C-D6F2-4EE8-8BC6-F5E248E1F840

P31

Q51822733-97416D18-FD91-4079-A444-4DF64EBF1D85

P356

Q51822733-321B089B-C25B-4206-9417-16A037E7D467

P433

Q51822733-AD3618C0-4BEF-4F8D-A13D-EE26033435B4

P478

Q51822733-C12FD738-5FAC-43FD-839E-292B9995562F

P50

Q51822733-3C6B7C0E-CD76-497E-B084-D2EA5473E35D

Q51822733-F601B8E6-52C9-4933-8827-D847ABE18A2A

P577

Q51822733-05124A12-B946-4C0F-8FE0-AF4AD9D88394

P698

Q51822733-21DD1AE3-F0AD-4FAB-AEE2-FD33C7EAFE74

P356

S11060-009-9934-0

P1433

Journal of Neuro-Oncology

P1476

WHO grade II and III meningiomas: a study of prognostic factors

@en

P2093

Anne Durand

http://www.w3.org/2001/XMLSchema#string

Anne Jouvet

http://www.w3.org/2001/XMLSchema#string

Jacques Guyotat

http://www.w3.org/2001/XMLSchema#string

Jean Jacques Moreau

http://www.w3.org/2001/XMLSchema#string

Luc Bauchet

http://www.w3.org/2001/XMLSchema#string

Michel Kalamaridès

http://www.w3.org/2001/XMLSchema#string

Michelle Fèvre-Montange

http://www.w3.org/2001/XMLSchema#string

Robert Deruty

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis and treatment of atypical and anaplastic meningiomas: a review.

World Health Organization Grades II and III meningiomas are rare in the cranial base and spine.

The WHO classification of tumors of the nervous system.

The recurrence of intracranial meningiomas after surgical treatment

Chemotherapy, hormonal therapy, and immunotherapy for recurrent meningiomas.

Meningioma pathology, genetics, and biology.

Meningioma: an update.

Epidemiology of intracranial meningioma.

The distribution of constitutional and somatic mutations in the neurofibromatosis 2 gene.

P2888

s11060-009-9934-0

P304

367-375

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-009-9934-0

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P50

Francois Labrousse

P577

2009-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19562258

http://www.w3.org/2001/XMLSchema#string